Constitutive Activation and Oncogenicity Are Mediated by Loss of Helical Structure at the Cytosolic Boundary of the Thrombopoietin Receptor
Preprint
Abstract
Dimerization of the thrombopoietin receptor (TpoR) is necessary for receptor activation and downstream signaling through activated Janus kinase 2. We have shown previously that different orientations of the transmembrane (TM) helices within a receptor dimer can lead to different signaling outputs. Here we addressed the structural basis of activation for receptor mutations S505N and W515K that induce myeloproliferative neoplasms. We show using in vivo bone marrow reconstitution experiments that ligand-independent activation of TpoR by TM asparagine (Asn) substitutions is proportional to the proximity of the mutation to the intracellular membrane surface. Solid-state NMR experiments on TM peptides indicate a progressive loss of helical structure in the juxtamembrane (JM) R/KWQFP motif with either proximity of Asn substitutions to the cytosolic boundary or mutation of W515 in the motif. Mutational studies in the TpoR cytosolic JM region show that the helical loss by itself can induce activation, but is localized to a maximum of 6 amino acids downstream of W515, the rest of the region until Box 1 requiring helicity for receptor function. The constitutive activation of TpoR mutants S505N and W515K can be inhibited by rotation of TM helices within the TpoR dimer, which also restores helicity around W515. Together these data allow us to develop a general model for activation and to explain the critical role of the JM W515 residue in the regulation of receptor activity. (Total manuscript without References and Figure Legends 6507 words, main text (without methods and materials):)Keywords
All Related Versions
- Published version: eLife, 12.
This publication has 47 references indexed in Scilit:
- Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617FNature Structural & Molecular Biology, 2012
- Orientation‐specific signalling by thrombopoietin receptor dimersThe EMBO Journal, 2011
- The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signalingNature Structural & Molecular Biology, 2011
- Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulationThe FASEB Journal, 2011
- MPL Mutation Profile in JAK2 Mutation-negative Patients With Myeloproliferative DisordersDiagnostic Molecular Pathology, 2011
- Cytokine receptors and hematopoietic differentiationOncogene, 2007
- gp130 dimerization in the absence of ligand: Preformed cytokine receptor complexesBiochemical and Biophysical Research Communications, 2006
- MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid MetaplasiaPLOS Medicine, 2006
- Janus Kinases Affect Thrombopoietin Receptor Cell Surface Localization and StabilityJournal of Biological Chemistry, 2005
- Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietinNature, 1994